Literature DB >> 1848670

Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.

A F Wilks1, A G Harpur, R R Kurban, S J Ralph, G Zürcher, A Ziemiecki.   

Abstract

The protein-tyrosine kinases (PTKs) are a burgeoning family of proteins, each of which bears a conserved domain of 250 to 300 amino acids capable of phosphorylating substrate proteins on tyrosine residues. We recently exploited the existence of two highly conserved sequence elements within the catalytic domain to generate PTK-specific degenerate oligonucleotide primers (A. F. Wilks, Proc. Natl. Acad. Sci. USA 86:1603-1607, 1989). By application of the polymerase chain reaction, portions of the catalytic domains of several novel PTKs were amplified. We describe here the primary sequence of one of these new PTKs, JAK1 (from Janus kinase), a member of a new class of PTK characterized by the presence of a second phosphotransferase-related domain immediately N terminal to the PTK domain. The second phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differs significantly from that of the PTK and threonine/serine kinase family members. A second member of this family (JAK2) has been partially characterized and exhibits a similar array of kinase-related domains. JAK1 is a large, widely expressed membrane-associated phosphoprotein of approximately 130,000 Da. The PTK activity of JAK1 has been located in the C-terminal PTK-like domain. The role of the second kinaselike domain is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848670      PMCID: PMC359893          DOI: 10.1128/mcb.11.4.2057-2065.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Molecular cloning of two types of GAP complementary DNA from human placenta.

Authors:  M Trahey; G Wong; R Halenbeck; B Rubinfeld; G A Martin; M Ladner; C M Long; W J Crosier; K Watt; K Koths
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Construction of phylogenetic trees.

Authors:  W M Fitch; E Margoliash
Journal:  Science       Date:  1967-01-20       Impact factor: 47.728

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins.

Authors:  A Kazlauskas; J A Cooper
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

6.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Authors:  M H Kraus; W Issing; T Miki; N C Popescu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.

Authors:  S C Kozma; S M Redmond; X C Fu; S M Saurer; B Groner; N E Hynes
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  119 in total

1.  Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.

Authors:  P Saharinen; K Takaluoma; O Silvennoinen
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Rat chromosome 1: regional localization of seven genes (Slc9a3, Srd5a1, Esr, Tcp1, Grik5, Tnnt3, Jak2) and anchoring of the genetic linkage map to the cytogenetic map.

Authors:  C Szpirer; J Szpirer; F Tissir; E Stephanova; P Vanvooren; T W Kurtz; N Iwai; T Inagami; M Pravenec; V Kren; K Klinga-Levan; G Levan
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

Review 3.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

4.  Regulation of insulin receptor substrate-2 tyrosine phosphorylation in animal models of insulin resistance.

Authors:  Fernanda Alvarez Rojas; Aparecida Emiko Hirata; Mario J A Saad
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

Review 5.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

6.  Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent.

Authors:  Rita Andraos; Zhiyan Qian; Débora Bonenfant; Joëlle Rubert; Eric Vangrevelinghe; Clemens Scheufler; Fanny Marque; Catherine H Régnier; Alain De Pover; Hugues Ryckelynck; Neha Bhagwat; Priya Koppikar; Aviva Goel; Lorenza Wyder; Gisele Tavares; Fabienne Baffert; Carole Pissot-Soldermann; Paul W Manley; Christoph Gaul; Hans Voshol; Ross L Levine; William R Sellers; Francesco Hofmann; Thomas Radimerski
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

7.  Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-γ.

Authors:  Geoff M Gordon; Que T Lambert; Kenyon G Daniel; Gary W Reuther
Journal:  Biochem J       Date:  2010-12-01       Impact factor: 3.857

8.  An indel polymorphism in the 3' untranslated region of JAK1 confers risk for hepatocellular carcinoma possibly by regulating JAK1 transcriptional activity in a Chinese population.

Authors:  Qiang Yu; Weifeng Qian; Jian Wang; Yejiao Wu; Jinkun Zhang; Weichang Chen
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

9.  A tyrosine kinase profile of prostate carcinoma.

Authors:  D Robinson; F He; T Pretlow; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

10.  The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage.

Authors:  A Eilers; D Seegert; C Schindler; M Baccarini; T Decker
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.